These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9381016)

  • 21. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The importance of C-peptide determination in the treatment and prognosis of type II diabetes].
    Válek J; Karasová L; Pelikánová T; Jirkovská A; Grafnetter D; Hammer J
    Cas Lek Cesk; 1990 Feb; 129(5):142-6. PubMed ID: 2184936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between fasting C-peptide and other clinical and metabolic variables in non-insulin-dependent diabetes mellitus.
    Seghieri G; Alviggi L; Caselli P; Breschi C; Mammini P; Gironi A; Bartolomei A; De Giorgio LA
    Quad Sclavo Diagn; 1988; 24(1-4):65-72. PubMed ID: 3268920
    [No Abstract]   [Full Text] [Related]  

  • 26. [Islet beta-cell function in failures following sulfonylurea therapy in diabetics, by determination of serum C-peptide].
    Costamaillere L; Arteaga A; Velasco N; Pellegrino MR; Foradori A; López G; Acosta AM
    Rev Med Chil; 1984 Dec; 112(12):1206-13. PubMed ID: 6399604
    [No Abstract]   [Full Text] [Related]  

  • 27. Glucagon-induced plasma C-peptide response in diabetic patients. Influence of body weight and relationship to insulin requirement.
    Scheen AJ; Castillo MJ; Lefèbvre PJ
    Diabetes Metab; 1996 Dec; 22(6):455-8. PubMed ID: 8985655
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical characteristics and hormonal-metabolic homeostasis in patients with insulin-dependent diabetes mellitus with stable and labile courses].
    Tikhonova EP; Levchenko TP; Pavliuchenko RV; Lavrova EV; Blokhina ZN
    Ter Arkh; 1984; 56(10):84-6. PubMed ID: 6395423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical course of recent insulin-dependent diabetes mellitus and possibilities of controlling it therapeutically].
    Dryáková M; Bartos V; Karasová L; Růzicková J; Lánská V; Malý J
    Cas Lek Cesk; 1990 Nov; 129(48):1516-9. PubMed ID: 2257600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [beta-Cell residual function in juvenile diabetes mellitus (author's transl)].
    Schober E; Schernthaner G; Frisch H
    Monatsschr Kinderheilkd; 1980 Dec; 128(12):776-9. PubMed ID: 6109242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of health resort treatment on insulin and C-peptide concentration in girls with insulin-dependent diabetes.
    Bonikowska-Zgaińska M
    Mater Med Pol; 1996; 28(4):115-31. PubMed ID: 9308334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The importance of strict control of blood glucose at the onset and during the remission stage in newly diagnosed diabetic children].
    Vavrinec J; Lébl J; Zizkovský V; Dvorák P; Snajderová M
    Cesk Pediatr; 1988 May; 43(5):325-8. PubMed ID: 3042170
    [No Abstract]   [Full Text] [Related]  

  • 33. [Progress in insulin therapy. V. Insulin therapy in noninsulin dependent diabetes mellitus].
    Szurkowska M; Nazim A; Sieradzki J
    Przegl Lek; 1992; 49(8):279-81. PubMed ID: 1302350
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of therapy-induced insulin antibodies on glycemic control in type 1 diabetes mellitus.
    Keilacker H; Rjasanowski I; Ziegler M
    Z Med Lab Diagn; 1989; 30(1):65-6. PubMed ID: 2655328
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical picture of slow-evolving insulin-dependent diabetes mellitus]("1 1/2")].
    Grosz A; Halmos T; Pánczél P; Kautzky L; Jakab A
    Orv Hetil; 1993 Jul; 134(30):1631-4. PubMed ID: 8341540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Importance of peptide C determination in diabetes].
    Halaby G; Karam J; Jambart S; Aydenian H; Zankoul R; Gannagé MH
    J Med Liban; 1989; 38(1):29-34. PubMed ID: 2519329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Metabolic criteria for the differential diagnosis of insulin-dependent and non-insulin-dependent diabetes mellitus].
    Iakovlev GM; Kozhemiakin LA; Rakov AL; Drygin AN; Sharapov GN
    Klin Med (Mosk); 1988 Jul; 66(7):55-8. PubMed ID: 3184828
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of C-peptide in children: when is it useful?
    Besser RE
    Pediatr Endocrinol Rev; 2013 Jul; 10(4):494-502. PubMed ID: 23957200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-peptide determination in the choice of treatment in diabetes mellitus.
    Koskinen P; Viikari J; Irjala K; Kaihola HL; Seppälä P
    Scand J Clin Lab Invest; 1985 Nov; 45(7):589-97. PubMed ID: 3906851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-peptide replacement therapy as an emerging strategy for preventing diabetic vasculopathy.
    Bhatt MP; Lim YC; Ha KS
    Cardiovasc Res; 2014 Nov; 104(2):234-44. PubMed ID: 25239825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.